Aditya Khemka

markets: How will Biosecure Act impact Indian pharma companies? Aditya Khemka explains

by
markets: How will Biosecure Act impact Indian pharma companies? Aditya Khemka explains

“There should be an alternate vendor that can support you, even if at higher prices or higher cost. So, I think that is where the Indian players come in. Remember, last we checked, Indian API exports were around $4 billion and that number compares to China’s API exports of roughly $40 billion,” says Aditya Khemka, … Read more

ETMarkets Smart Talk: There will be political stability; healthcare could turn out to be the dark horse in FY25: Aditya Khemka

by
ETMarkets Smart Talk: There will be political stability; healthcare could turn out to be the dark horse in FY25: Aditya Khemka

“Healthcare as a sector could turn out to be the dark horse in FY25,” says Aditya Khemka – Fund Manager, InCred Asset Management. In an interview with ETMarkets, Khemka said: “One could allocate higher capital to relatively smaller companies which are reasonably valued and would likely participate meaningfully in the Indian growth story,” Edited excerpts: … Read more